Tissue Regenix Group PLC
XBER:LSW1
Tissue Regenix Group PLC
XBER:LSW1
Price:
0.59
EUR
-0.84%
Market Closed
Market Cap:
€8.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Tissue Regenix Group PLC
XBER:LSW1
|
UK |
|
O
|
Oil-Dri Corporation of America
F:O4D
|
US |
|
C
|
Comtech Telecommunications Corp
F:CC6
|
US |
|
RSWM Ltd
BSE:500350
|
IN |
|
U
|
Ultragenyx Pharmaceutical Inc
SWB:UP0
|
US |
|
Q
|
Qualcomm Inc
F:QCI
|
US |
|
Race Oncology Ltd
ASX:RAC
|
AU |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LSW1's stock price target?
Not Available
LSW1 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Tissue Regenix Group PLC?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 2 years is 9%.
What is the Operating Income forecast for Tissue Regenix Group PLC?
Projected CAGR
137%
137%
The compound annual growth rate for Operating Income over the next 2 years is 137%.
